title: Renal transplantation in HBsAg+ patients: is lamivudine your "final answer"?
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Fontana
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D019694:Hepatitis B, Chronic / Q000517:prevention & control*; D006526:Hepatitis C / Q000517:prevention & control*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D019259:Lamivudine / Q000627:therapeutic use*; D011182:Postoperative Care; D006435:Renal Dialysis
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D019259:Lamivudine